Back to top

Image: Bigstock

Is Tivity Health (TVTY) a Suitable Stock for Value Investors?

Read MoreHide Full Article

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Tivity Health, Inc. stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:

PE Ratio

A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.

On this front, Tivity Health has a trailing twelve months PE ratio of 18.91, as you can see in the chart below:
 

Zacks Investment Research
Image Source: Zacks Investment Research

This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 stands at about 20.40. If we focus on the long-term PE trend, Tivity Health’s current PE level puts it above its midpoint over the past five years.
 

Zacks Investment Research
Image Source: Zacks Investment Research

Further, the stock’s PE also compares favorably with the sector’s trailing twelve months PE ratio, which stands at 25.63. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.
 

Zacks Investment Research
Image Source: Zacks Investment Research

We should also point out that Tivity Health has a forward PE ratio (price relative to this year’s earnings) of just 16.86, so it is fair to say that a slightly more value-oriented path may be ahead for Tivity Health stock in the near term too.

P/S Ratio

Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.

Right now, Tivity Health has a P/S ratio of about 3.13. This is lower than the S&P 500 average, which comes in at 4.38 right now. As we can see in the chart below, this is above the median for this stock in particular over the past few years.
 

Zacks Investment Research
Image Source: Zacks Investment Research

TVTY is actually in the higher zone of its trading range in the time period per the P/S metric, which suggests that the company’s stock price has already appreciated to some degree, relative to its sales.

Broad Value Outlook

In aggregate, Tivity Health currently has a Zacks Value Style Score of B, putting it into the top 40% of all stocks we cover from this look. This makes Tivity Health a solid choice for value investors, and some of its other key metrics make this pretty clear too.

For example, its P/CF ratio (another great indicator of value) comes in at 15.56, which is better than the industry average of 16.88. Clearly, TVTY is a solid choice on the value front from multiple angles.

What About the Stock Overall?

Though Tivity Health might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth grade of F and a Momentum score of D. This gives TVTY a Zacks VGM score—or its overarching fundamental grade—of D. (You can read more about the Zacks Style Scores here >>)

Meanwhile, the company’s recent earnings estimates have been mixed at best. The current quarter has seen zero estimates go higher in the past sixty days compared to three lower, while the full year estimate has seen two upward and two downward revisions in the same time period.

As a result, the current quarter consensus estimate has fallen by 4.5% in the past two months, while the full year estimate has been unchanged.

This somewhat mixed trend is why the stock has just a Zacks Rank #3 (Hold) and why we are looking for in-line performance from the company in the near term.

Bottom Line

Tivity Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. However, with a sluggish industry rank (among the bottom 33%) and a Zacks Rank #3, it is hard to get too excited about this company overall. In fact, over the past two years, the industry has clearly underperformed the broader market, as you can see below:
 

Zacks Investment Research
Image Source: Zacks Investment Research

So, value investors might want to wait for estimates, analyst sentiment and broader factors to turn around in this name first, but once that happens, this stock could be a compelling pick.

Published in